Opportunities for Deep Tech Startups Amid Covid-19 Pandemic
East Ventures, a venture capital company that actively invests in Indonesian startups, launched a program called Indonesia Pasti Bisa to develop and produce 100 thousand test kits for Covid-19. East Ventures runs the program through Nusantics, a genomics technology company in its investment portfolio. Nusantics implements advanced genomic research for consumer products and will produce 100 test kit prototypes before producing 100 thousand test kits.
In a press release, Nusantics said it would run a genome sequencing on the new coronavirus. This step is vital because Covid-19 continues to mutate to adapt to the host and its environment. Therefore, this phase is needed in the research and development of antivirus for Covid-19 in Indonesia.